IL-SUREWERX
11.7.2024 23:01:29 CEST | Business Wire | Press release
SureWerx®, a leading global provider of safety, tool & equipment products, announced today that it has acquired FALL SAFE®. Terms were not disclosed.
Based in Porto, Portugal, FALL SAFE® is a global leader of critical-use personal protective equipment, specializing in fall protection equipment and systems. Since 2003, the company has been recognized as a category leader and innovator of highly technical and functional safety products for diverse end markets. FALL SAFE® designs and manufactures a wide variety of fall protection safety products including harnesses, self-retracting lifelines (SRL’s), descenders, belts, anchors, ropes, lifelines as well as other technical fall protection products including various safety accessories. FALL SAFE® continues to lead through innovation, with the sole purpose of keeping workers safe and protecting the lives of countless professionals working at heights around the globe. As part of the transaction, FALL SAFE® TRAINING, a fully certified training facility, helps to train workers at heights from around the globe.
“Adding FALL SAFE to our growing, world-class portfolio of SureWerx brands moves us further toward our goal of becoming the global leader in Safety and Productivity,” said SureWerx CEO, Chris Baby. “FALL SAFE brings us one step closer to building a robust and innovative Fall Protection portfolio as part of the SureWerx platform. FALL SAFE’s expertise in the most technical and demanding portion of the Fall Protection market around the globe sets them apart from their competition. We are thrilled to be adding this highly respected brand to our market-leading portfolio of best-in-class safety products.”
“FALL SAFE has always focused on delivering innovative, performance-driven products and solutions to end users through its distribution partners,” said FALL SAFE Founders, Jan and Paula Ekman. “We are thrilled to be partnering with SureWerx, a company that holds the same values and commitment to worker safety as FALL SAFE. Their reach into the global industrial markets and access to over 4,000 distributors across multiple channels will undoubtedly accelerate growth of the FALL SAFE brand. We are in good hands - the future for FALL SAFE has never been brighter!”
About SureWerx
Co-headquartered in Vancouver, Canada, and Elgin, Illinois, SureWerx is a leading global manufacturer of professional safety products, tools, and equipment. SureWerx markets its safety products under multiple brands including Jackson Safety®, Sellstrom®, Pioneer®, PeakWorks®, ADA Solutions®, Armor Tile, Access Tile, Due North®, K1 Series®, Avenger, Nautilus®, MEGAComfort, NEOS®, Oberon and now FALL SAFE®.
SureWerx offers unparalleled access to its brands through its distributor network servicing the industrial, construction, safety, electrical, utilities, resources, transportation, automotive aftermarket, and food production markets globally. For more information visit: www.surewerx.com.
About FALL SAFE
Headquartered in Porto, Portugal and founded in 2003, FALL SAFE specializes in designing and manufacturing innovative, performance-based working at heights safety products for professional workers. Products and training serve most industrial and construction channels and users around the globe. For more information please visit: www.fallsafe-online.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711650843/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom